[ Price : $8.95]
FDA approves AstraZenecas Imfinzi (durvalumab) in combination with Bacillus Calmette-Guerin (BCG) for treating adults with BCG-nav...[ Price : $8.95]
BrainStorm Cell Therapeutics names former FDA associate commissioner Peter Pitts to its board of directors.[ Price : $8.95]
An FDA advisory committee recommends updating Covid-19 vaccines for the 2026-2027 immunization season to target the currently domi...[ Price : $8.95]
FDA warns Springfield, MA-based physician Adnan Dahdul about Bioresearch Monitoring violations in his conduct of a clinical invest...[ Price : $8.95]
FDA extends by 30 days the comment period on a request for information entitled AI-Enabled Optimization of Early-Phase Clinical Tr...[ Price : $8.95]
Eli Lilly says it is acquiring three vaccine developers in deals worth up to $3.8 billion combined, expanding its push into infect...[ Price : $8.95]
FDA cites Dabur India Limited for significant manufacturing and data integrity violations at an over-the-counter drug manufacturin...[ Price : $8.95]
Researchers say manufacturers could make better use of predetermined change control plans for AI-enabled medical devices.